2018•Medical OncologyRequires access

Comparison of the clinical outcomes of nilotinib and dasatinib therapies in newly diagnosed patients in the chronic phase of chronic myeloid leukemia: a retrospective analysis

Noriyoshi Iriyama, Keiji Sugimoto, Eriko Sato, Tomoiku Takaku, Michihide Tokuhira, Tomonori Nakazato, Maho Ishikawa, Hiroyuki Fujita, Isao Fujioka, Yuta Kimura, Norio Asou, Masahiro Kizaki, Norio Komatsu, Yoshihiro Hatta, Tatsuya Kawaguchi

Open publisher page 7 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 7 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Nilotinib, Dasatinib, Medicine, Internal medicine, Imatinib, Myeloid leukemia, Tyrosine-kinase inhibitor, Hematology